Non-invasive Ventilation and Dexmedetomidine in Critically Ill Adults: a Vanguard Pragmatic Randomized Controlled Trial (inDEX Trial)
Latest Information Update: 01 Mar 2024
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Respiratory insufficiency
- Focus Therapeutic Use
- Acronyms inDEX
- 26 Feb 2024 Status changed from recruiting to active, no longer recruiting.
- 04 Jan 2024 Planned number of patients changed from 100 to 30.
- 04 Jan 2024 Planned End Date changed from 30 Dec 2023 to 1 Apr 2024.